Stocks and Investing Stocks and Investing
Tue, June 6, 2023
Mon, June 5, 2023
Sat, June 3, 2023
Fri, June 2, 2023

Raghuram Selvaraju Reiterated (VRNA) at Strong Buy and Held Target at $32 on, Jun 2nd, 2023


Published on 2024-10-28 04:09:34 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $32 on, Jun 2nd, 2023.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Edward Nash of "Canaccord Genuity" Maintained at Sell with Increased Target to $33 on, Wednesday, May 10th, 2023
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Monday, March 20th, 2023